Navigation Links
Catalent Announces Appointment of Sally Langa as New Vice President of Development and Analytical Services
Date:1/21/2016

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products, today announced the appointment of Sally Langa to the position of Vice President, Business Development, for Catalent’s Development and Analytical Services offerings. In this role, Ms. Langa will be responsible for growing Catalent’s early phase development business for small molecule compounds, including analytical services, formulation development, and micronization.

Ms. Langa joins Catalent from Halo Pharma where she held the role of Vice President, Sales and Marketing. Her career within the pharmaceutical services industry, which spans almost thirty years, has also seen her hold a number of senior positions at Patheon.

“Sally brings a huge amount of experience to Catalent and will be a pivotal part of the team charged with meeting the company’s ambitious growth targets,” commented Jonathan Arnold, Vice President and General Manager of Advanced Delivery Technologies. “Catalent sees great growth potential in its early stage development activities, as well as continued opportunity to integrate these services further into the clinical and commercial phases of development.”

Ms. Langa is an active member of the Drug, Chemical and Associated Technologies (DCAT) Association, and is currently on the Technology Committee. She is also a Trustee on the Board of the Pharma & Biopharma Outsourcing Association (PBOA).

Catalent’s Development and Analytical services, located at sites throughout the US and Europe, offer global solutions with specialty handling capabilities for controlled substances, highly potent, cytotoxic, and temperature critical compounds, to handle the most challenging molecules.

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2016/01/prweb13175195.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
2. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
3. Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
4. Catalent and Minomic Collaborate to Bring New Prostate Cancer Treatment to Market
5. Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference
6. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
7. Catalent Announces Two Senior Appointments to its Biologics Business
8. Bioavailability and Controlled Release Symposium Announced by Catalent Applied Drug Delivery Institute
9. Best Practice and Strategies in Risk Mitigation to be Presented by Catalent Expert at Internal Audit Summit
10. New OptiPact™ Technology Introduced by Catalent
11. Catalent and Cingulate Therapeutics Sign Exclusive Agreement for Development of New ADHD Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2019)... ... May 23, 2019 , ... Carrie Romandine, RevSpring’s vice president of ... Women in Healthcare IT . , This is the fourth year that HDM ... given to women in the following professional categories:, CIOs/HIT ...
(Date:5/23/2019)... ... May 23, 2019 , ... ... today announced that Lean Human Capital has selected the winners of its ... Human Capital by HealthcareSource has recognized excellence in healthcare recruitment. All winners have ...
(Date:5/23/2019)... Calif. (PRWEB) , ... May 23, 2019 , ... ... Qualia line of nootropic products, has recently partnered with Emerson Ecologics. Qualia Mind, ... and their online Practitioner dispensary platform Wellevate. With Emerson’s extensive nearly 40 year ...
(Date:5/22/2019)... ... May 23, 2019 , ... 5 Design Change Considerations to Stay Compliant ... https://www.fdanews.com/5designchange , Do devicemakers read the fine print when changing a design? ... i’s and cross all the t’s may result in inspection failures as well as ...
(Date:5/22/2019)... ... May 22, 2019 , ... In the U.S. in 2014, according to the ... the last step in the in vitro fertilization (IVF) process. This represents an 83% ... Mark P. Trolice, Director of Fertility CARE: The IVF Center , emphasizes that ...
Breaking Medicine News(10 mins):
(Date:5/24/2019)... Fla. (PRWEB) , ... May 24, 2019 , ... Laurence ... be opening a segment that discusses the new tools utilized in veterinary care on ... available in the industry. The world of animal medicine has seen some amazing technological ...
(Date:5/23/2019)... JACKSONVILLE, Fla. (PRWEB) , ... May 23, 2019 , ... ... version of the company’s visual identity. After releasing a new logo and name extension ... , The new website is designed to be extremely user-friendly with key elements found ...
(Date:5/23/2019)... ... 23, 2019 , ... The recent measles outbreaks have highlighted ... childhood immunizations are credited with preventing 20 million illnesses and more than 40,000 ... million deaths every year [2]. , For vaccines to do this essential work, ...
Breaking Medicine Technology: